National POLA Network for the Treatment of High-Grade Oligodendroglial Tumours FRESH-PEF9222-en Caroline DEHAIS National POLA Network for the Treatment of High-Grade Oligodendroglial Tumours POLA FRESH-PEF9222-en 9222 FRESH-PEF9222 Jean-Yves DELATTRE Epidemiology France Portal (PEF) null Jean-Yves;DELATTRE oligodendrogliomas molecular profiling clinical trial Oncology Neurology Oligodendroglioma, anaplastic Oligoastrocytoma, NOS Glioblastoma of brain The objectives of the POLA network for high-grade oligodendroglial tumours are threefold: - To harmonise tumour diagnosis techniques through the systematic organisation of a double histological analysis of tumour samples and their molecular characterisation Therapeutic treatment harmonisation. - Research development for rare tumours through the creation of a clinical database closely associated with the conservation of tumour samples and its accessibility to neuro-oncology research teams. - Distribution of information and knowledge among health professionals, patients and those close to them. null France Individuals Patients population Male Female Young Adult (19 to 24 years) Adult (25 to 44 years) Middle Aged (45 to 64 years) Aged (65 to 79 years) Aged, 80 and over (80 years and more) anaplastic oligodendroglioma, anaplastic oligoastrocytoma, glioblastoma with oligodendroglial component recently diagnosed. Clinical data Biological data Paraclinical data (non-biological) : Imaging Health event/morbidity Health event/mortality Quality of life/health perception Other [500-1000[ individuals Converting or copying information into a structured record Interview with the participant (including clinical) Observational Study Observational Study Over 1,000 patients have benefited from the network organisation since its creation. Unknown Restricted access Access on specific project only